In cancer cell lines, the genetic deletion or chemical inhibition of CDK12 kinase activity has virtually no effect on CDK13 protein levels, and never leads to such a dramatic downregulation seen in growing oocytes [13, 39]. The gene discussed is CDK13; the disease is cancer.